Predicting Favorable Outcomes in Hospitalized Covid-19 Patients

COVID Clinical Trial

Official title:

Predicting Favorable Outcomes in Hospitalized Covid-19 Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04570488
• Other study ID #: PAU COVID19
• Status: Completed
• Start date: May 15, 2020
• Est. completion date: December 7, 2021

Study information

• Verified date: December 2022
• Source: NYU Langone Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Testing use of predictive analytics to predict which COVID-19+ patients are at low risk for an adverse event (ICU transfer, intubation, mortality, hospice discharge, re-presentation to the ED, oxygen requirements exceeding nasal cannula at 6L/Min) in the next 96 hours

Description:

To assess if display of low risk of adverse event in EPIC can safely reduce length of stay and plan for discharge.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1415
• Est. completion date: December 7, 2021
• Est. primary completion date: December 7, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria: Adult hospitalized COVID19+ patients predicted to have no adverse event at 96 events with a threshold at 90% PPV, with at least one low risk during their admission who are discharged alive and have not been in the ICU

Exclusion Criteria: Age < 18 years not hospitalized for COVID19+.

Related Conditions & MeSH terms

• Adverse Event
• Corona Virus Infection
• Coronavirus Infections
• COVID

Intervention

Other:
• EPIC risk score display
Display of risk score/ colored flag in Epic patient list column

Locations

Country	Name	City	State
United States	NYU Langone Health	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Re-presentation to ED		96 hours
Other	Readmission to hospital		96 hours
Other	Mortality		96 hours
Other	Postdischarge mortality		96 hours
Primary	Reduction in days from first low-risk score to discharge	Reduction in days from first low-risk score to discharge	96 Hours
Secondary	Reduction in length of stay (LOS)	Reduction in LOS for green patients that have not been in the ICU	96 hours
Secondary	Reduction in GTD vs. LOS	Reduction in GTD vs. LOS for all green patients discharged alive vs all patients discharged alive	96 hours
Secondary	No change in 30 day re-ED presentation or hospital admission rate for cohort	No change in 30 day re-ED presentation or hospital admission rate for cohort	96 hours